Protection of Germinal Epithelium with Luteinizing Hormone-Releasing Hormone Analogue
- 1 July 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 134 (1) , 187-190
- https://doi.org/10.1016/s0022-5347(17)47054-6
Abstract
A dog model for chemotherapy and radiation-induced testicular damage was created to study the protective potential of superactive analog of LHRH, buserelin. Buserelin appeared to offer protection of the canine germinal epithelium against cyclophosphamide, cisplatinum and radiation. Clinical trials with buserelin in patients of reproductive age undergoing treatment for cancer should be encouraged.This publication has 16 references indexed in Scilit:
- Recovery from aspermia induced by low-dose radiation in seminoma patientsCancer, 1982
- Effects of chemotherapy on testicular functionsInternational Journal of Andrology, 1982
- PROTECTION FROM CYCLOPHOSPHAMIDE-INDUCED TESTICULAR DAMAGE WITH AN ANALOGUE OF GONADOTROPIN-RELEASING HORMONEThe Lancet, 1981
- Effects of cancer chemotherapy on gonadal function of patientsCancer Treatment Reviews, 1980
- Male Contraception; Synergism of Gonadotropin-Releasing Hormone Analog and Testosterone in Suppressing GonadotropinScience, 1980
- Chronic Effects of [D-Trp6,Pro9-NEt]Luteinizing Hormone-Releasing Factor on Reproductive Processes in the Male Rat*Endocrinology, 1979
- Extra-pituitary inhibition of testicular function by luteinising hormone releasing hormoneNature, 1979
- Testicular Damage Due to Cytotoxic Drugs and Recovery after Cessation of TherapyAustralian and New Zealand Journal of Medicine, 1978
- Alkylating Agents andJAMA, 1971
- Inhibition and recovery of spermatogenesis in rats, monkeys, and dogs medicated with bis(dichloroacetyl)diaminesExperimental and Molecular Pathology, 1962